COMP <GO>
ACMR vs ACLS // RETURN ON INVESTED CAPITAL (ROIC)
ACM Research Inc. (Class A) (NASDAQ) VS. Axcelis Technologies Inc. (NASDAQ) • 15-METRIC TALLY: ACMR 2
— ACLS 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ACLS
LAST: $49.29 (-7.03%) • MKT CAP: $3.43B
roic
9.80%
LAST: $112.02 (-1.50%) • MKT CAP: $3.46B
roic
10.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACMR VS. ACLS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACMR | ACLS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.40% | 44.90% | -0.50 | ACLS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 9.80% | 10.60% | -0.80 | ACLS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.2x | 25.7x | -7.50 | ACMR | /valuation <GO> |
| Free Cash Flow Yield | -1.94% | 3.09% | -5.03 | ACLS | /fcf-yield <GO> |
| Operating Margin | 12.10% | 14.20% | -2.10 | ACLS | /operating-margins <GO> |
| Net Profit Margin | 10.40% | 14.30% | -3.90 | ACLS | /net-margins <GO> |
| Revenue Growth (YoY) | 15.20% | -17.60% | +32.80 | ACMR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.50 | 8.43 | -4.93 | ACLS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.2 | 35.1 | -7.96 | ACLS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.7x | 26.8x | +3.90 | ACLS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.43B | $3.46B | -$26.3M | ACLS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACMR REV | ACLS REV | ACMR GROSS % | ACLS GROSS % | ACMR FCF | ACLS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $901.3M | $839.0M | 44.4% | 44.9% | -$66.6M | $107.0M |
| FY 2024 | $782.1M | $1.02B | 50.1% | 44.7% | $70.0M | $128.6M |
| FY 2023 | $557.7M | $1.13B | — | — | -$75.3M | $156.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACMR // BETA —
ACLS // BETA —